BREAST-CANCER MARKER CA-549 AND ITS COMPARISON WITH CA-15.3

被引：0
|
作者：
BHARGAVA, A [1 ]
FERNG, S [1 ]
PALMER, M [1 ]
PETRELLI, N [1 ]
FITZPATRICK, J [1 ]
机构：
[1] ROSWELL PK CANC INST,BUFFALO,NY 14263
来源：
CLINICAL CHEMISTRY | 1990年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [21] A COMPARISON OF CA-549 WITH CA-15-3 AND MCA IN PATIENTS WITH METASTATIC BREAST-CANCER
    DEWIT, R
    HOEK, FJ
    BAKKER, PJM
    VEENHOF, CHN
    ANNALS OF ONCOLOGY, 1992, 3 (04) : 314 - 315
  • [22] SERUM CA549 IN PRIMARY BREAST-CANCER - COMPARISON WITH CA15.3 AND MCA
    GION, M
    PLEBANI, M
    MIONE, R
    PENZO, C
    MEO, S
    BURLINA, A
    BRITISH JOURNAL OF CANCER, 1994, 69 (04) : 721 - 725
  • [23] CA-15.3: Prognostic factor in breast cancer
    Vialard, F
    Basuyau, JP
    Gligorov, J
    Boccara, C
    Graic, Y
    Veyret, C
    Julien, JP
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S100 - S100
  • [24] SERUM MARKERS FOR BREAST-CANCER - CA-549 OR CA-15-3
    CHAN, DW
    BRUZEK, DJ
    KINZLER, JK
    BEVERIDGE, RA
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1051 - 1052
  • [25] CLINICAL-STUDY OF CA-549 AS A SERUM TUMOR-MARKER FOR BREAST-CANCER
    FRITSCHE, HA
    GAUR, PK
    TUMOR BIOLOGY, 1987, 8 (06) : 346 - 346
  • [26] SERUM LEVELS OF CA-15.3 IN CLINICAL MANAGEMENT OF PATIENTS WITH BREAST-CANCER
    MOLINA, R
    BALLESTA, AM
    CASALS, E
    MARIN, JL
    GUAL, J
    ELENA, M
    BALAGUE, A
    TUMOUR BIOLOGY, 1985, 6 (04): : 349 - 349
  • [27] MARKERS IN BREAST-CANCER - DOES CEA ADD TO THE DETECTION BY CA-15.3
    DELARUE, JC
    MOURIESSE, H
    DUBOIS, F
    FRIEDMAN, S
    MAYLEVIN, F
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 11 (03) : 273 - 276
  • [28] CIRCULATING CA-549 AND OTHER ASSOCIATED ANTIGENS IN BREAST-CANCER PATIENTS
    PAVESI, F
    LOTZNIKER, M
    SCARABELLI, M
    MAURO, E
    VISCONTI, G
    NICOLATO, E
    MORATTI, R
    ONCOLOGY, 1994, 51 (01) : 18 - 21
  • [29] COMPARISON OF TUMOR-MARKERS CEA, CA-125, CA-15.3 AND PROLACTIN LEVELS IN PATIENTS WITH ADVANCED BREAST-CANCER
    TSAVARIS, N
    VONORTA, K
    SARAFIDOU, M
    BACOYIANNIS, C
    MYLONAKIS, N
    BEER, M
    PAPAGRIGORIOU, D
    KOUTSIOUBAKAZAKOU, P
    KOSMIDIS, P
    DIAGNOSTIC ONCOLOGY, 1992, 2 (04): : 211 - 219
  • [30] CA 15.3 - EARLY RESULTS OF A NEW BREAST-CANCER MARKER
    COLOMER, R
    SOLE, LA
    NAVARRO, M
    ENCABO, G
    RUIBAL, A
    SALVADOR, L
    ANTICANCER RESEARCH, 1986, 6 (04) : 683 - 684
12345